English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[Features of retinopathy of prematurity, progressing as "plus-disease"].

Vestnik Oftalmologii 2002 November
"Plus-disease" is a particular grave form of retinopathy of premature babies found in 7% of extremely premature and somatically loaded children. The following criteria are indicative of "plus-disease": location of pathological changes in the central zone of eye fundus (zone 1-2), marked vascular activity and hemorrhages in the center and on the periphery of the retina, pupil regidity, iris vasodilatation and fulminant (3 days-3 weeks) progression of the process from initial signs up to signs of extraretinal growth or exudative amotio retinae without forming premature stages typical for retinopathy (torus lines). Upon revealing the first signs of "plus-disease" ophthalmological examinations should be carried out with the interval of 2-3 days. To increase efficiency of preventive treatment it is recommended to use the combined procedure of cryo- and laser coagulation of avascular zones and a zone of vascular amostosis in appearance of extraretinal vascular growth, which makes it possible to arrest disease progression in 75% of cases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app